Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that as of December 7, 2018, Health Canada authorized Natural MedCo Ltd., a wholly-owned subsidiary of the Company, to use its previously constructed 100,000 sq. ft. second flowering room as a grow area, and a packaging room as an operations area. 

With the addition of these approved areas, Eve & Co now has 220,000 sq. ft. of licenced grow and operation areas. The Company expects harvesting to commence at its newly licenced second flowering room by late March 2019.

Natural MedCo Ltd. has also received authorization to commence sales of additional types of cannabis products, including fresh and dried cannabis, to provincially authorized retailers and distributors. Eve & Co is now authorized to sell a variety of cannabis products to provincially authorized retailers and distributors, including fresh and dried cannabis and cannabis plants, and to other licenced cultivators and processors on the B2B market, including fresh and dried cannabis, cannabis plants and cannabis oil.

“The addition of Flowering Room #2 will allow us to more than double our current production levels and to grow in our new, state of the art flowering room.  Approval for Packaging Room #2 will allow us to start using our automated packaging line to efficiently and quickly fill orders in immediate packaging.  The amendment to our sales license expands our market to not only other licensed producers but also to provincial distributors,” commented Melinda Rombouts, Eve & Co’s President and CEO. “We have agreements for supply to Ontario, British Columbia and Newfoundland, and we hope to commence shipment to provincial distributors as soon as possible.  Our team is excited to move forward with these amendments, as well as the next 780,000 sq. ft. expansion and development of our brand, Eve & Co.”